Jackob Moskovitz

Jackob Moskovitz

Apr 23, 2019

Group 6 Copy 187
-1
Please wait...

About This Project

Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are climate change and air pollution triggering cardiovascular disease?

Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

Managing Congenital Adrenal Hyperplasia in the Amish Population

Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Campaign Ended

A medicine project funded by 45 people